"Idaho Urologic Institute, PA is dedicated to providing Idaho’s most advanced urologic care for men, women, and children. Our goal is to deliver high-quality, innovative care by offering the best and newest treatment modalities to improve your urologic health and quality of life. For your convenience we have offices in Boise, Meridian, Mountain Home and Nampa, Idaho. Our Meridian facility features an outpatient surgery center (Surgery Center of Idaho), outpatient diagnostic imaging services, clinical research department, full-service reference lab that includes a comprehensive infertility lab, and a technologically advanced radiation oncology care center."

During the past decade, Idaho Urologic Institute-Meridian conducted 145 clinical trials. In the 10-year time frame, 145 clinical trials started and 53 clinical trials were completed, i.e. on average, 36.6% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 37 clinical trials were completed. i.e. 108.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Idaho Urologic Institute-Meridian" #1 sponsor was "National Cancer Institute (NCI)" with 74 trials, followed by "Alliance for Clinical Trials in Oncology" with 36 trials sponsored, "SWOG Cancer Research Network" with 29 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology" with 18 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Idaho Urologic Institute-Meridian" #1 collaborator was "National Cancer Institute (NCI)" with 99 trials as a collaborator, "NRG Oncology" with 14 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Genentech, Inc." with 3 trials as a collaborator and "Millennium Pharmaceuticals, Inc." with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 29 trials.

According to Clinical.Site data, the most researched conditions in "Idaho Urologic Institute-Meridian" are "Invasive Breast Carcinoma" (10 trials), "Metastatic Malignant Neoplasm in the Brain" (7 trials), "Prostate Cancer" (7 trials), "Stage IV Lung Cancer AJCC v8" (7 trials) and "Stage IIIA Breast Cancer" (6 trials). Many other conditions were trialed in "Idaho Urologic Institute-Meridian" in a lesser frequency.

Most popular intervention types in "Idaho Urologic Institute-Meridian" are "Drug" (153 trials), "Other" (93 trials), "Biological" (71 trials), "Procedure" (52 trials) and "Radiation" (24 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (39 trials), "Quality-of-Life Assessment" (38 trials), "Biospecimen Collection" (28 trials), "Questionnaire Administration" (28 trials) and "Computed Tomography" (27 trials). Other intervention names were less common.

The vast majority of trials in "Idaho Urologic Institute-Meridian" are 155 trials for "All" genders, 25 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "Idaho Urologic Institute-Meridian". undefined are not yet recruiting, 62 are recruiting, 86 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 30 completed trials in Idaho Urologic Institute-Meridian, 6 suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Idaho Urologic Institute-Meridian, 7 "Phase 1" clinical trials were conducted, 99 "Phase 2" clinical trials and 92 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".